Article Details
Retrieved on: 2024-05-18 16:53:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The firm presently has an “equal weight” rating on the biotechnology company's stock. Morgan Stanley's price objective would suggest a potential ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here